Akeso Biomedical, Waltham, Mass., Assigned Patent for Reduction of Gastrointestinal Tract Colonisation By Campylobacter
Copyright © Targeted News Service, 2017
2017-05-27
Copyright © Targeted News Service, 2017
2017-05-27
ALEXANDRIA, Va., May 27 -- Akeso Biomedical, Waltham, Massachusetts, has been assigned a patent (9,655,912) developed by two co-inventors for the "reduction of gastrointestinal tract colonisation by campylobacter." The co-inventors are Jafar Mahdavi, Nottingham, United Kingdom, and Dlawer Ala'Aldeen, Nottingham, United Kingdom.
The patent application was filed on Feb. 15, 2013 (14/379,473). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1 . . .
The patent application was filed on Feb. 15, 2013 (14/379,473). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1 . . .